Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-425,000
Closed -$2.51M 20
2021
Q4
$2.51M Sell
425,000
-125,000
-23% -$913K 1.68% 15
2021
Q3
$4.82M Buy
550,000
+900
+0.2% +$7.8K 3.54% 10
2021
Q2
$5.63M Sell
549,100
-900
-0.2% -$7.51K 3.81% 10
2021
Q1
$3.66M Hold
550,000
2.71% 10
2020
Q4
$4.72M Buy
+550,000
New +$3.71M 4.02% 9

Other funds holding NEPH

Samjo Capital's NEPH Position: Q1 2022 in Review

Samjo Capital sold out of Nephros (NEPH) in Q1 2022, closing a stake of 425,000 shares — an estimated $2.51M sold.

Samjo Capital first reported a position in NEPH in Q4 2020 and held it in 5 quarters. The position peaked at $5.63M in Q2 2021. 16 funds tracked by Wall St. Rank hold NEPH as of Q1 2022.

  • Samjo Capital reported no remaining Nephros position as of Q1 2022 after selling out during the quarter.
  • Samjo Capital sold 425,000 Nephros shares in Q1 2022, an estimated $2.51M.
  • Samjo Capital first reported a position in Nephros in Q4 2020 and held it in 5 quarters.
  • Samjo Capital's Nephros position peaked at $5.63M in Q2 2021.
  • 16 funds tracked by Wall St. Rank held Nephros as of Q1 2022.

Based on Samjo Capital's 13F filing for Q1 2022, filed 16 May 2022.